Skip to main content
Clinical Trials/IRCT20170108031818N3
IRCT20170108031818N3
Not yet recruiting
Phase 3

Investigating the effect of midazolam on the incidence of restlessness and agitation in patients undergoing electroshock therapy at 5 Azar Hospital in Gorgan in 2023

Gorgan University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Patients undergoing electroshock therapy.
Sponsor
Gorgan University of Medical Sciences
Enrollment
100
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Gorgan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • The patient diagnosed with psychosis is indicated for ECT

Exclusion Criteria

  • Age range 18\-75 years
  • Patient satisfaction to conduct research

Outcomes

Primary Outcomes

Not specified

Similar Trials